Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

1Life Healthcare $282 million IPO

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $281.75 million initial public offering by 1Life Healthcare, Inc…

Grupo Aval $1 billion global notes offering

Davis Polk advised Grupo Aval Acciones y Valores S.A. in connection with its global offering of $1 billion aggregate principal amount of 4.375% senior notes due 2030. The notes were issued…

Alector $240 million stock offering

Davis Polk advised the underwriters in connection with Alector, Inc.’s $240 million public offering of 9,602,500 shares of common stock, which includes the 1,252,500 shares offered pursuant…

Black Diamond Therapeutics $231.3 million IPO

Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…

Denali Therapeutics $207 million stock offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $207 million public offering of common stock of Denali Therapeutics,…
Back to top